U.S. Behavioral Health Care Software And Services Market (By Component: Software, Support Services; By Delivery Model; By Function; By End Use) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Behavioral Health Care Software And Services Market 

5.1. COVID-19 Landscape: U.S. Behavioral Health Care Software And Services Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global U.S. Behavioral Health Care Software And Services Market, By Component

8.1. U.S. Behavioral Health Care Software And Services Market, by Component, 2022-2030

8.1.1. Software

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Support Services

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global U.S. Behavioral Health Care Software And Services Market, By Function

9.1. U.S. Behavioral Health Care Software And Services Market, by Function e, 2022-2030

9.1.1. Clinical

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Administrative

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Financial

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global U.S. Behavioral Health Care Software And Services Market, By Delivery Model 

10.1. U.S. Behavioral Health Care Software And Services Market, by Delivery Model, 2022-2030

10.1.1. Ownership

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Subscription

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global U.S. Behavioral Health Care Software And Services Market, By End-use 

11.1. U.S. Behavioral Health Care Software And Services Market, by End-use, 2022-2030

11.1.1. Providers

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Payers

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Patients

11.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global U.S. Behavioral Health Care Software And Services Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Component (2017-2030)

12.1.2. Market Revenue and Forecast, by Function (2017-2030)

12.1.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.1.4. Market Revenue and Forecast, by End-use (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Function (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Component (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Function (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End-use (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Component (2017-2030)

12.2.2. Market Revenue and Forecast, by Function (2017-2030)

12.2.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.2.4. Market Revenue and Forecast, by End-use (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Function (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Component (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Function (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End-use (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Component (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Function (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End-use (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Component (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Function (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End-use (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Component (2017-2030)

12.3.2. Market Revenue and Forecast, by Function (2017-2030)

12.3.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.3.4. Market Revenue and Forecast, by End-use (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Function (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Component (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Function (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End-use (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Component (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Function (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End-use (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Component (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Function (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End-use (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Component (2017-2030)

12.4.2. Market Revenue and Forecast, by Function (2017-2030)

12.4.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.4.4. Market Revenue and Forecast, by End-use (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Function (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Component (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Function (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End-use (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Component (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Function (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End-use (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Component (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Function (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End-use (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.5.2. Market Revenue and Forecast, by Function (2017-2030)

12.5.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Function (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End-use (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Component (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Function (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Delivery Model (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End-use (2017-2030)

Chapter 13. Company Profiles

13.1. Cerner Corporation

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Core Solutions, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Epic

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Meditab

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Holmusk

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Netsmart Technologies

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Qualifacts Systems, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Welligent, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. SimplePractice, LLC

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. TherapyNotes, LLC

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms